Technology
Health
Biotechnology

Alkermes

517

$14.40
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.07%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Alkermes and other stocks, options, ETFs, and crypto commission-free!

About ALKS

Alkermes plc Ordinary Shares, also called Alkermes, is a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. Its products include Aristada, which is used for the treatment of schizophrenia in adults; and Vivitrol, which is an injectable medication for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence, following opioid detoxification. Read More The company was founded on May 4, 2011 and is headquartered in Dublin, Ireland.

CEO
Richard F. Pops
Employees
2,235
Headquarters
Dublin, Dublin
Founded
2011
Market Cap
2.23B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.97M
High Today
$14.69
Low Today
$13.62
Open Price
$13.99
Volume
1.78M
52 Week High
$37.75
52 Week Low
$11.98

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Medical
Pharmaceutical
Europe (Non-UK)
Europe

ALKS Earnings

-$0.22
$0.13
$0.48
$0.83
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected Apr 23, Pre-Market

People Also Bought

Activision Blizzard

50,057

$57.10

-1.07%

Activision Blizzard

50,057

$57.10

-1.07%

Gilead Sciences

41,995

$73.11

-1.02%

Bristol-Myers Squibb

9,865

$52.79

+1.03%

Under Armour

24,002

$9.44

-4.55%

You May Also Like

JSML
HTEC
TMDX
RAAX
PLIN
FITBP
AMBC+
ISCF
BSCN
IMAC
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy ALKS

Market Price$14.40
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Alkermes stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up